Study shows chain of events that a Parkinson's risk gene can trigger

A new study is shedding light on the complex biological processes that may lead to Parkinson’s disease. Researchers have identified a chain of events linking genetic factors to disruptions in how the body processes fats, or lipids, ultimately contributing to the development of the debilitating neurological condition.

Unraveling the Genetic Link

Parkinson’s disease is the second most prevalent neurodegenerative condition worldwide, following Alzheimer’s. The research, conducted by teams at the US’ Baylor College of Medicine and Duncan Neurological Research Institute, focused on a common Parkinson’s risk gene called SPTSSB. This gene is crucial for the initial stages of sphingolipid production – lipids essential for cell interaction, growth, and programmed cell death.

Did You Know? Researchers studied healthy individuals *before* the onset of Parkinson’s symptoms to understand how genetic variations impact lipid levels.

The Role of the rs1450522 Variant

The study specifically examined a variant of the SPTSSB gene, known as rs1450522, which has been linked to an increased risk of Parkinson’s. Dr. Joshua Shulman, a professor at Baylor College of Medicine, explained that while over 100 genes have been identified as increasing risk, understanding *how* these genetic changes lead to the disease remains a significant challenge.

Researchers analysed blood samples from individuals carrying the rs1450522 variant who were currently healthy, showing no symptoms like tremors or stiffness. They found that this variant increases the amount of SPTSSB protein in brain neurons and elevates levels of sphingolipids in the blood. Specifically, 23% of the 62 sphingolipids measured were significantly altered in those with the genetic variant compared to those without it.

Lipid Changes and Parkinson’s

The study also revealed broader changes in lipid profiles. Individuals with Parkinson’s disease had lower levels of certain fatty acids compared to those without the condition. Interestingly, healthy individuals carrying the SPTSSB variant exhibited higher levels of sphingolipids *and* lower levels of specific fatty acids.

Expert Insight: The identification of lipid changes in both healthy carriers of the gene variant and those with established Parkinson’s suggests that these metabolic shifts may be critical early events in the disease process.

These findings reinforce the idea that Parkinson’s susceptibility genes are actively involved in lipid metabolism, and that disruptions in lipid function could directly contribute to the brain changes associated with the disease.

What’s Next?

The research team validated their findings using data from thousands of individuals, confirming that the rs1450522 variant increases Parkinson’s risk by increasing SPTSSB protein levels and altering lipid profiles. Dr. Shulman believes that even small changes in lipid levels could provide valuable insights into the mechanisms driving Parkinson’s disease.

Researchers are now exploring whether these lipid changes could serve as early diagnostic markers, potentially detectable through a simple blood test. Currently, diagnosis often occurs after significant brain damage has already occurred, limiting treatment options to symptom management. A possible next step could involve developing tests to identify individuals at risk *before* symptoms appear.

Frequently Asked Questions

What role do sphingolipids play in this research?

Sphingolipids are essential lipids involved in cell-cell interaction, cell proliferation, cell migration, and cell death. The study found that the rs1450522 gene variant alters levels of these lipids in the blood.

What is the significance of the SPTSSB gene?

The SPTSSB gene regulates the initial steps of sphingolipid production. The study found that a variant of this gene, rs1450522, is linked to an increased risk of developing Parkinson’s disease.

Is there a way to diagnose Parkinson’s disease early?

Currently, early diagnosis remains a challenge. Researchers are exploring whether changes in lipid levels could serve as potential early diagnostic markers detectable in a blood test, but sensitive and specific tests are still needed.

As our understanding of the intricate link between genetics, lipid metabolism, and Parkinson’s disease grows, could this research pave the way for preventative strategies and more effective treatments for this devastating condition?

Study shows chain of events that a Parkinson’s risk gene can trigger